Publications by authors named "Marta Garofoli"

Claim this Profile
I
Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Claudia Bartolini, Marta Garofoli

J Am Heart Assoc· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Blood pressure: the lower the better? Maybe yes].
Paolo Verdecchia, Fabio Angeli, Adolfo Aita, Claudia Bartolini, Marta Garofoli

G Ital Cardiol (Rome)· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications.
Fabio Angeli, Gianpaolo Reboldi, Cristina Poltronieri, Ludovico Lazzari, Martina Sordi, Marta Garofoli

Ther Adv Cardiovasc Dis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive blood pressure lowering is dangerous: the J-curve: con side of the arguement.
Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Marta Garofoli, Gianpaolo Reboldi

Hypertension· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to morning surge, dipping, and sleep-time blood pressure as prognostic markers of cardiovascular risk.
Paolo Verdecchia, Marta Garofoli, Fabio Angeli, Gianpaolo Reboldi

Hypertension· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of circadian blood pressure changes in relation to differing measures of day and night.
Paolo Verdecchia, Fabio Angeli, Claudia Borgioni, Salvatore Repaci, Massimo Guerrieri, Marta Garofoli

J Am Soc Hypertens· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis.
Fabio Angeli, Gianpaolo Reboldi, Marta Garofoli, Elisa Ramundo, Cristina Poltronieri

Curr Cardiol Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins in acute coronary syndrome: very early initiation and benefits.
Fabio Angeli, Gianpaolo Reboldi, Giovanni Mazzotta, Marta Garofoli, Maria Francesca Cerasa

Ther Adv Cardiovasc Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications.
Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Marta Garofoli, Elisa Ramundo

Hypertension· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose combination therapy in hypertension: cons.
Fabio Angeli, Gianpaolo Reboldi, Giovanni Mazzotta, Marta Garofoli, Elisa Ramundo

High Blood Press Cardiovasc Prev· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome.
Fabio Angeli, Gianpaolo Reboldi, Marta Garofoli, Elisa Ramundo, Paolo Verdecchia

Acute Card Care· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions.
Fabio Angeli, Gianpaolo Reboldi, Giovanni Mazzotta, Cristina Poltronieri, Marta Garofoli

Curr Drug Saf· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies for osteoarthritis patients with pain and hypertension.
Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Paola Martire, Marta Garofoli

Ther Adv Musculoskelet Dis· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The optimal blood pressure target for patients with coronary artery disease.
Paolo Verdecchia, Fabio Angeli, Claudio Cavallini, Giovanni Mazzotta, Marta Garofoli

Curr Cardiol Rep· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aliskiren versus ramipril in hypertension.
Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Paola Martire, Marta Garofoli

Ther Adv Cardiovasc Dis· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the definition of daytime and nighttime blood pressure prognostically relevant?
Paolo Verdecchia, Fabio Angeli, Mariagrazia Sardone, Claudia Borgioni, Marta Garofoli

Blood Press Monit· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ambulatory blood pressure monitoring in clinical practice].
Fabio Angeli, Gianpaolo Reboldi, Salvatore Repaci, Marta Garofoli, Matteo Casavecchia

G Ital Cardiol (Rome)· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Antihypertensive therapy and cardiovascular prevention. The role of angiotensin II receptor blockers].
Paolo Verdecchia, Claudio Cavallini, Fabio Angeli, Francesco Andreani, Marta Garofoli

G Ital Cardiol (Rome)· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis